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Background: Paediatric hepatic steatosis is highly prevalent and closely related to type 
2 diabetes.  
Aims: To determine whether the addition of supervised exercise to a family-based 
lifestyle- and psycho-educational intervention results in greater reduction of percentage 
hepatic fat (HF), adiposity, and cardiometabolic risk factors in children with 
overweight/obesity. 
Methods: The study subjects of this non-randomized, two-arm, parallel design, clinical 
trial were 116 overweight/obese children (10.6±1.1 years, 53.4% girls) living in Vitoria-
Gasteiz (Spain).  For 22 weeks they followed either a lifestyle- and psycho-education 
program (control intervention [CI], N=57), consisting of two family-based education 
sessions/month, or the same plus supervised exercise (intensive intervention [II], N=59) 
focused mainly on high-intensity aerobic workouts (3 sessions/week, 90 min/session). 
The primary outcome was the change in percentage HF (as measured by MRI) between 
baseline and the end of the intervention period. Secondary outcomes included changes 
in body mass index (BMI), fat mass index (FMI), abdominal fat (measured by dual-X-
ray-absorptiometry), blood pressure, triglycerides, high density lipoprotein, low density 
lipoprotein, gamma-glutammyl-transferase, glucose and insulin concentrations. 
Results: A total of 102 children completed the trial (N=53 and N=49 in the CI and II 
groups, respectively). Percentage HF decreased only in the II group (-1.20±0.31% vs. 
0.04±0.30%, II and CI, respectively), regardless of baseline value and any change in 
adiposity (P<0.01). BMI, FMI, abdominal fat (P≤0.001) and insulin (P<0.05) were 
reduced in both groups.  
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Conclusions: Multicomponent intervention programs that include exercise training may 
help reduce, adiposity, insulin resistance and hepatic steatosis in overweight/obese 
children. 
KEYWORDS: hepatic steatosis, childhood, physical activity, nutrition, psychology, 
obesity 




Children with overweight/obesity are at greater risk of developing cardiovascular 
diseases (CVD), type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) in 
adulthood1,2, and even in childhood.3 Paediatric NAFLD is affecting to nearly 34% of 
children with obesity.4 It is estimated that by 2025, 38 million will have hepatic 
steatosis, the earliest manifestation of NAFLD.5  
Paediatric hepatic steatosis is an independent risk factor for type 2 diabetes.6,7 
Excessive body mass gains during childhood may eventually induce the histological 
features of adult NAFLD.8 The treatment of overweight/obesity before puberty, 
however, can reduce the risk of developing type 2 diabetes in adulthood9. The early 
treatment of childhood overweight/obesity and its comorbidities is therefore vital. 
Currently, there is no pharmacological options for NAFLD in children.10 
Lifestyle modification is therefore the primary option.10 A systematic review of lifestyle 
interventions for the treatment of overweight/obesity in children aged 6-11 years 
observed that multicomponent behavior-changing programs achieved small, short-term 
reductions in body mass index (BMI).11 However, no studies have examined the effect 
of a non-hypocaloric diet-based lifestyle intervention program on percentage hepatic fat 
(HF) in children.  
Exercise training seems to be effective in reducing HF in adolescents12, and in 
reducing the risk of developing CVD and type 2 diabetes13 in children. In a systematic 
review,12 it was reported that supervised exercise, designed following the international 
recommendations of physical activity, reduced HF in youths. However, there has been 
no such study exclusively involving children under 12 years of age, and certainly none 
that has employed imaging methods to assess HF.  
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Given the above, lifestyle and behavioral modifications plus exercise training 
might be expected to have greater effects on HF (as well as on children's health and 
psychological well-being) than interventions based on lifestyle modifications alone. The 
aim of the present work was to determine whether a multicomponent intervention 
program designed according to current evidence and guidelines, and including a family-
based lifestyle and psycho-education program plus a supervised exercise intervention, is 
more effective at reducing percentage HF than the lifestyle program alone, in children 
with overweight/obesity aged 8 to 12 years. The effects of these interventions on fat 
mass, CVD and type 2 diabetes risk factors, physical fitness, dietary habits, physical 
activity and psychological well-being, are also discussed.  
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MATERIALS AND METHODS 
Study design 
The EFIGRO project is a non-randomized two-arms parallel-design controlled trial 
(ClinicalTrials.gov ID: NCT02258126).14 The study was conducted at the University of 
the Basque Country in Vitoria-Gasteiz (northern Spain), from September 2014 to June 
2017. The Euskadi Clinical Research Ethics Committee approved the study protocol 
(PI2014045), which complies with the ethical guidelines of the Declaration of Helsinki 
(2013 revision). All parents/legal guardians gave their informed, written consent for 
their children to be included in the study; the children also gave their assent before 
enrolment.  
The EFIGRO project compared differences on changes in percentage hepatic fat, 
cardiometabolic and diabetes risk factors between two groups: one group received a 
family-based lifestyle and psycho-educational program (hereinafter referred as the 
control intervention, CI) and another group received the same intervention plus an 
exercise program (hereinafter referred as the intensive intervention, II).  
Participants 
Children and their families were recruited at the Pediatric Endocrinology Unit of the 
University Hospital of Araba, and at Primary Care Clinics in the city of Vitoria-Gasteiz. 
The main entry criterion was having overweight/obesity, as defined by the cut-offs for 
sex and age (by month) established by the World Obesity Federation.15 All children had 
to be aged 8-12 years. Subjects whose medical condition or medication limited their 
physical activity, or that might affect the results obtained, were excluded. None of the 
children had diabetes mellitus or any other endocrine disorder, and all were non-
smokers. 
Assignment to intervention arms and blinding 
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Children were allocated into the CI or the II groups after baseline measurements. The 
design of the current project was conceived as a RCT; however, this assignment was not 
completely random. A number of children/ families (N=11) did not have time to attend 
the exercise sessions and were thus allocated to the CI group. This decision was taken 
since the children/families had been encouraged to participate in the study by their 
pediatricians, citing probable health benefits. 
Neither the staff delivering the intervention nor the study subjects were blinded 
to the arm assignment. However, the researcher in charge of analyzing the outcomes 
were thus blinded.  
Intervention protocols 
Lifestyle and psycho-educational program: Both the CI and the II groups, participated 
in the lifestyle and psycho-educational program. Parents/caregivers and children 
attended separately the lifestyle (45 min) and psycho-educational (45 min) program 
once every two weeks (i.e., 11 sessions in total), as explained in detail elsewhere.14 The 
focus of the program was to increase 1) the parents' and children's knowledge about 
healthier dietary habits, 2) their physical activity level, and 3) to promote sleep hygiene. 
The aim of the the psycho-educational program was to provide skills to the 
parents/caregivers in order to optimize the family environment for making positive 
lifestyle changes, and to learn assertive communication skills. The program also 
provided skills to children for managing their emotions and feelings, and improving 
their self-esteem and psychological well-being. 
Design of the supervised exercise program: Only the II group subjects took part in the 
exercise program. The full design of the program is available elsewhere.14 Children 
attended three sessions per week. Briefly, sessions were designed and supervised by 
exercise specialists and consisted of 5 min instruction time, 10 min of warm-up, 60 min 
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of game-based cardiovascular endurance, 10 min of muscle strength exercises, and 5 
min of cooling-down and stretching exercises (overall, 90 min/session). Subjects were 
encouraged through motivation and game strategies to spend as much time as possible 
during the session in the vigorous-high intensity physical activity.16 The maximum heart 
rate was defined as the highest value obtained during the cardiopulmonary exercise test 
in the laboratory, or in the 20msrt. Children wore a Polar RS300X HR monitor during 
the sessions for recording exercise intensity.16 
Participant retention and addressing compliance and adherence: The attendance of 
both the children and their parents/caregivers at the lifestyle and psycho-educational 
sessions was recorded. In the exercise program, children were marked “absent” if they 
did not attend a session or refused to participate in the proposed games or activities. 
Regardless of their adherence record, all subjects were encouraged to return for post-
intervention data collection 
Measurements 
Primary and secondary outcomes were assessed at baseline and after 22 weeks of 
intervention by the same trained researchers.  
Primary outcome measure: percentage hepatic fat  
Percentage HF was measured by magnetic resonance imaging (MRI) using a 
MAGNETOM Avanto 1.5T system (Siemens Healthcare, Erlangen, Germany) equipped 
with a phased-array surface coil and a spine array coil and and running Siemens 
Medical System software v.syngo.MR B17A, following the manufacturer's 
instructions.17 Children with ≥5.5% HF were deemed to have hepatic steatosis.18 
Secondary outcomes measurements 
Physical examination and body composition: Body mass and height were measured in 
duplicate. The cut points established by the World Obesity Federation 
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(http://www.worldobesity.org/) by sex and for each month of age were used to define 
overweight and obesity. 15 Pubertal stage was recorded by a pediatrician.19 Systolic and 
diastolic blood pressure was measured following recommendations for children20. 
Participants were deemed hypertensive when their systolic or diastolic blood pressure 
was >90th age-, sex- and height specific percentile.20  
Total and abdominal fat, as well as lean mass, were measured by dual energy X-
ray absorptiometry using a HOLOGIC, QDR 4500W device. The fat mass index (FMI) 
was then determined as [FMI: fat mass (kg)/stature2 (m2)] and lean mass index [LMI: 
lean mass (kg)/stature2 (m2)].  
Physical fitness: Cardiorespiratory fitness (CRF) and muscle strength were determined 
following validated protocols for children.21 Briefly, CRF was assessed by two tests: 1) 
an incremental CRF treadmill protocol with respiratory gas analysis until exhaustion, 
and 2) the 20m shuttle run test (20msrt). Upper and lower body muscular strength were 
assessed by the handgrip and the standing broad jump tests respectively.  
Biochemical measurements: Plasma triglycerides (TG), high density lipoprotein 
cholesterol (HDLc), low density lipoprotein cholesterol (LDLc), insulin, glucose and 
gamma-glutamyl transferase (GGT) concentrations were determined as reported 
elsewhere.14 The insulin resistance-homeostatic model assessment index (HOMA) and 
the TG/HDLc ratio were then calculated. Insulin resistance was defined according to the 
age- and sex-specific cut-points for HOMA values.22 Subjects with TG/HDLc values of 
≥2.0 were deemed to be at increased cardiometabolic risk.23  
Physical activity, sedentary time, sleep and dietary habits assessment: Physical activity 
was determined by accelerometry (wGT3X-BT, Actigraph, Pensacola, FL, USA) and 
dietary habits were assessed using two non-consecutive 24h recall records and food 
frequency questionnaires, as detailed elsewhere.14  
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Psychological assessment: Anxiety was assessed using the State-Trait Anxiety 
Inventory for Children; stress was determined using the Children's Daily Stressors 
Inventory; self-concept was assessed using the Self-Concept Form-5 Questionnaire; and 
depression examined using the translated version of the Children's Depression 
Inventory.14  
Statistical analyses 
Since no information on the effect of exercise on percentage HF in children was 
available, the required sample size was calculated using information available for 
closely associated secondary outcome variables. The sample size actually obtained was 
N=116. This figure was expected to provide at least 80% power for detecting an effect-
size (Cohen' d) between the two experimental groups of 0.7 for insulin resistance and 
total body fat (minimum number required in each group = 34 for 80% power and 
α=0.05). 
The baseline characteristics of the subjects' in the two intervention groups were 
compared using either the Student-t-test (for continuous variables) or the Chi-squared 
test (for categorical variables). Differences between the intervention groups in terms of 
post-intervention values for the primary and secondary outcomes were also examined 
using the Student-t-test. Within-group differences (pre vs. post values) in primary and 
secondary outcomes were examined using the Student paired t test following per 
protocol and intention-to-treat principles. For the intention-to-treat analyses, missing 
values at follow-up were obtained by multiple imputation using the following predictor 
variables: pre-intervention values, post-intervention values, age, sex, and intervention 
group. Imputations were performed as four blocks: body composition variables (HF, 
body mass, BMI, FMI, LMI, abdominal fat), blood pressure variables (systolic and 
diastolic blood pressure), cardiometabolic risk variables (TG, HDLc, LDLc, TG/HDLc, 
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insulin, glucose, HOMA, GGT), and fitness variables (VO2 peak, endtime treadmill test, 
20msrt result, handgrip strength, and standing broad jump).  
In both the per protocol and the intention-to-treat analyses, differences between 
the CI and II groups in terms of changes in primary and secondary outcomes were 
examined by analysis of covariance adjusting for baseline values. Cohen’s d was used 
to estimate the effect size and 95% confidence interval (95% CI). Differences between 
the CI and II groups in terms of changes in the percentage HF were examined in 
extended models: Model 1, unadjusted; Model 2, adjusted by the corresponding baseline 
value and changes in height; Model 3, adjusted by baseline values and changes in the 
FMI; Model 4, adjusted by baseline values and changes in abdominal fat.  
Finally, the relationship between the changes (pre- to post-intervention values) 
in physical fitness variables and in percentage HF in each intervention group (CI and II) 
were examined by regression analysis, 1) using an unadjusted model, and 2) adjusting 
for baseline physical fitness and percentage HF. 
Significance was set at p<0.05. All calculations were made using the Statistical 





Figure 1 shows the flow chart for the trial, plus subject inclusions and exclusions. 
Table 1 shows the participants' baseline characteristics. Overall, there were no 
significant differences in the socioeconomic, sociodemographic, anthropometric or 
clinical characteristics between the CI and II groups.  
A total of 102 of the original 116 subjects (87.9%; N=53 in the CI group and N= 
49 in the II group) successfully completed the trial, attending at least 50% of the 
sessions. Their data were included in the per protocol analyses. The data for those 
children that discontinued the intervention (N=4 in the CI group and N=9 in the II 
group, or who did not attend at least 50% of the educational program sessions (N=1, in 
the II group), were also included in the intention-to-treat analyses.  
Attendance, adverse events and main characteristics of the program 
No significant difference was seen between the CI and II groups in terms of attendance 
at the lifestyle- and psycho-education program sessions, either for the parents/caregivers 
(86.4±12.9% vs. 80.6±15.3%; P=0.334) or the children (87.2±12.0% vs. 82.5±14.6%; 
P=0.496). The mean attendance rate for the II subjects with respect to the exercise 
program was 72.0±16.1% sessions. Exercise-related adverse events included knee and 
ankle pain (N=2); no adverse events were recorded for the lifestyle- and psycho-
education program. 
In the exercise program, the mean HR per session was 146±16 bpm. High 
intensity exercise was maintained for 49±23% of the time, and moderate intensity 
exercise for 32±15% of the time. 
Effects of the intervention on primary outcome 
Percentage hepatic fat  
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No significant difference in percentage HF was seen between the CI and II groups at 
baseline (Table 2 and Supplemental Table 1, for the per protocol and intention-to-treat 
analyses, respectively). Although there were no significant differences in post-
intervention values of percentage HF between the two groups (Tables 2 and 
Supplemental Table 1), only children in the intensive group reduced percentage HF 
after the intervention (Table 2 and Supplemental Table 1, for the per protocol and 
intention-to-treat analyses, respectively). The difference in the change in percentage HF 
between the two groups (per protocol analysis) was significant (P<0.02, Figure 2 and 
Supplemental Figure 1); these results persisted after adjustment for baseline values for 
percentage HF and changes in height (-1.20±0.31 vs. 0.04±0.30% for the II and CI 
group respectively; P=0.006), and when changes in FMI (-1.13±0.27 vs. -0.02±0.27% 
for the II and CI groups respectively; P=0.004) and abdominal fat (-1.19±0.26 vs. -
0.03±0.28% for the II and CI groups; P=0.004) were adjusted for instead of changes in 
height (Supplemental Figure 1). Further adjustment for baseline VO2peak (measured via 
the treadmill test) did not substantially alter the results (P<0.05). The intention-to-treat 
analyses for differences between groups in terms of the change in percentage HF 
returned similar results (Supplemental Figure 2).  
Effects of the intervention on secondary outcomes 
Adiposity and CVD and type 2 diabetes risk factors 
No significant differences were seen between the CI and II groups in terms of any of the 
studied cardiometabolic or type 2 diabetes risk factors at baseline (Tables 2 and 
Supplemental Table 1). Both groups returned significantly reduced BMI, FMI and 
abdominal fat values after the intervention (P<0.01), while no significant changes were 
seen in LMI (Table 2 and Supplemental Table 1 for the per protocol and intention-to-
treat analyses respectively. No significant differences were seen between the groups in 
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terms of post-intervention in any adiposity estimate (Table 2 and Supplemental Table 
1). The reduction in BMI was significantly greater in the II group (P<0.01), but no 
significant differences were seen between the groups in terms of the change in FMI or 
abdominal fat (Figure 2). These results did not substantially differ after adjusting for 
baseline values (Supplemental Figure 2). The intention-to-treat analyses returned 
similar results (Supplemental Figure 3). 
Per protocol analysis showed the insulin concentration and HOMA value to be 
significantly smaller (P<0.01 and P<0.05 respectively) in the CI group after the 
intervention (Table 2).  These reductions were not significant, however, in the intention-
to-treat analysis (P<0.09, Supplemental Table 1). In the II group, the HDLc (P<0.01), 
LDLc (P<0.001), insulin (P<0.05) and GGT (P<0.05) concentrations all decreased 
significantly by the end of the intervention program (per protocol analysis). Diastolic 
blood pressure increased significantly in the II group, while no significant change was 
observed in the control group (Table 2). The intention-to-treat analysis returned similar 
results, but only the changes in TG (P<0.05), insulin (P<0.001) and GGT (P<0.01) 
remained significant (Supplemental Table 1).   
No significant differences were seen in terms of post-intervention 
cardiometabolic and diabetes risk factors between the two groups (Tables 2 and 
Supplemental Table 1), except with respect to the LDLc level (P<0.05; both per 
protocol and intention to treat).  However, greater reductions in LDLc were seen in the 
II group than in the CI group after the intervention; the per protocol and the intention-
to-treat analyses returned similar results (Figure 2, and Supplemental Figures 2 and 3).  
In the per protocol analysis, significant difference was seen between the groups 
in terms of the effect of the interventions on TG (P<0.05, Table 2), but this was 
attenuated in the intention-to-treat analyses (P<0.07, Supplemental Table 1). However, 
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the differences in the change in TG were not consistent between the per protocol (Figure 
2 and Supplemental Figure 2) and intention-to-treat analyses (Supplemental Figure 3). 
Similarly, analysis-inconsistent differences were seen between groups in terms of the 
effect of the interventions on GGT levels (Figure 2, and Supplemental Figures 2 and 3).  
Physical fitness  
At baseline, VO2peak as measured by the treadmill test was lower in the II than in the 
CI group (P<0.05), but no significant differences were seen in the rest of the fitness 
variables (Table 2 and Supplemental Table 1). Significant increases were seen in both 
groups for all physical fitness variables after the intervention (P≤0.001, Table 2 and 
Supplemental Table 1), but no significant differences were seen between them in terms 
of the changes in these values (Figure 2), even after adjustment for baseline values 
(Supplemental Figure 2). The intention-to-treat analysis returned similar results 
(Supplemental Figure 3).  
 The increase in CRF measured in the 20msrt was significantly associated with 
the reduction in percentage HF content in the II group subjects -at least in the per 
protocol analysis (Supplemental Table 2). This relationship was attenuated and 
became non-significant (P<0.06) in the intention to treat analysis. (Supplemental Table 
3).  
Effects of the intervention on lifestyle and psychological well-being factors 
All comparisons were per protocol (Supplemental Table 4). No significant differences 
in dietary and physical activity variables were seen between the two groups at baseline. 
By the end of the intervention, both groups had significantly reduced their energy and 
fat intake and increased their intake of fruits and vegetables. No significant changes 
were seen, however, in the consumption of sugar and sugar-sweetened beverages. 
Neither MVPA nor sleep time changed after the intervention in either group, although 
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sedentary time was significantly reduced in the II group (P<0.05). No significant 
differences in dietary or physical activity variables were seen between the two groups at 
the end of the intervention.  
No significant differences were seen in psychological variables between the two 
groups at baseline (Supplemental Table 4). By the end of the intervention, the subjects 
of both groups had experienced a significant increase in terms of emotional self-concept 
(P<0.05). Improvements were also seen in physical self-concept, total depression, 
dysphoria and anxiety, although they were only significant in the CI group (P<0.05 and 
P<0.09, for the CI and II intervention groups, respectively). No significant differences 
in the improvement in psychological well-being were seen between the two groups at 





The present results reveal the II subjects to have experienced a clinically important 
reduction (nearly 20%) in percentage HF; no such reduction was seen in CI group. Both 
the CI and II subjects experienced a reduction in total and abdominal fat and insulin 
resistance. The II subjects also enjoyed a significant reduction in LDLc. Given the 
importance of treating pediatric hepatic steatosis early -not only to prevent future liver 
damage but also type 2 diabetes- these findings should be taken into account in pediatric 
obesity management programs.  
Family-based lifestyle education programs accompanied with psychological 
support are recommended for the treatment and prevention of paediatric obesity and 
related comorbidities.25 However, the the present study shows that while the educational 
program followed was able to effectively reduce adiposity and insulin resistance, it was 
unable to reduce the percentage HF of the children. Hepatic fat was only reduced in 
those who participated in the supervised exercise program in addition to the lifestyle 
education program. These results agree with those of a study involving obese 
adolescents26, in which a 4-month intervention focused on changing the quality of 
carbohydrate intake resulted in significant improvements in insulin sensitivity -but only 
a combined lifestyle, psycho-education and resistance exercise training program 
resulted in a reduction in percentage HF. 
As far as we are aware, the present work is the first to report the additional effect 
of supervised exercise on HF as measured by MRI in children. Other studies have 
reported significant reductions in HF after aerobic or resistance exercise training 
interventions, but in adolescents.13,27–29 In a recent systematic review and meta-analysis, 
it was reported that exercise training at moderate-to-vigorous or vigorous intensity, in 
sessions of at least 60 minutes, and a frequency ≥3 sessions per week are effective 
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reducing HF content in youth.12 The present findings are in agreement with these 
recommendations.  
In adults and adolescents with overweight or obesity, lifestyle interventions 
including exercise -or not- have been reported to significantly reduce HF.30,31 However, 
these programs were based on hypocaloric diets that caused large body mass losses.31,32 
In the present study -which involved pre-adolescent children- the lifestyle education 
program was not designed to achieve body weight loss in the short term, and certainly 
the CI subjects lost no body mass or lean mass.  
A systematic review and meta-analysis comparing the effect of exercise training 
and a hypocaloric diet on visceral adiposity33 reported the latter to result in a larger 
body mass loss, whereas exercise training tended to induce larger reductions in visceral 
adiposity. Interestingly, in the present work, the effects of exercise on percentage HF 
were independent of the change in total or abdominal fat, suggesting a direct metabolic 
effect of exercise training on HF metabolism.  
Family-based, structured lifestyle modification programs combined with 
behavioral strategies for treating obesity have been associated with adiposity reductions 
in children.34 In the present study, the children's dietary habits were improved with 
respect to the development of obesity after the 22-week intervention. Improvements 
were also seen in several components of self-concept, depression, stress and anxiety in 
children. These improvements in both dietary habits and psychological health are quite 
notable.  
Physical activity was not increased at the end of the intervention in either the CI 
or II group; indeed, in the CI group there was even a trend towards a reduction in total 
physical activity. It should also be noted that several families declined to participate in 
the II arm given the relatively large number of sessions involved. A possible solution 
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might be to reduce the number of session per week or the duration of each session. 
Future studies examining the effectiveness of less intensive exercise programs on 
percentage HF and cardiometabolic risk in overweight/obese children are warranted.  
One of the strengths of this study is the use of MRI for measuring percentage 
HF. Moreover, the sample size was also larger, and the duration of the intervention 
program longer than in previous studies.13,27,28 Of note is, however, that several families 
did not agree to participate in the intensive intervention due to the relatively elevated 
number of sessions which may comprise the feasibility of the intensive program. There 
are, however, some limitations that should be mentioned. The most important limitation 
of the study is its not entirely strict randomization 14. This may limit the validity of the 
results. However, the participants in both groups were comparable at baseline, and 
adjustments for potential baseline differences between groups were made in analyses. 
Finally, the results were not adjusted for multiple comparisons.   
Conclusion 
A family-based, multicomponent intervention program including supervised exercise 
training and lifestyle- and psycho-education, designed following international 
recommendations for obesity prevention and health promotion in children, was shown 
to have the potential to reduce HF, total and abdominal fat, and insulin resistance, and 
to improve dietary habits and psychological well-being, in pre-adolescents children with 
overweight/obesity. These findings highlight the importance of promoting such 
programs as part of pediatric obesity treatment: improvements may be achieved not 
only in total and abdominal fat and insulin resistance, but also in hepatic steatosis, a 
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Figure 1. Flow chart showing enrollment into the study groups. Control intervention 
group: children participating in the family-based lifestyle- and psycho-educational 
program; Intensive intervention group: children participating in the latter plus exercise 
training. 
 
Figure 2. Unadjusted effect size (d-Cohen and 95% CI) and differences in changes (∆) 
in percentage hepatic fat, body mass and composition, cardiometabolic and diabetes risk 
factors between the control group (children participating in the family based lifestyle 
and psycho-educational program) and intensive groups (children participating in the 
multicomponent intervention including lifestyle and psycho-educational program). 
Differences between the control and the intensive intervention groups in terms of 
changes in primary and secondary outcomes were examined (per protocol) by ANOVA. 
Changes were calculated as post-intervention minus pre-intervention values. Data are 
means (standard deviation). *Negative Cohen's d values obtained for the differences in 
the changes in adiposity and cardiometabolic and diabetes risk between the two groups 
(in favor of the II group) were multiplied by -1 for illustrative purposes. HDL: high 
density lipoprotein cholesterol; HOMA: homeostasis model assessment; TG/HDL: 
triglycerides to high density lipoprotein ratio; LDL: low density lipoprotein; GGT: 
gamma glutamyl transferase; VO2peak: peak oxygen consumption from the treadmill test; 
20msrt: performance in the 20 meters shuttle run test.  
 
Supplemental Figure 1. Change in percentage hepatic fat in the group of children 
participating in the lifestyle- and psycho-educational program (grey bars, control), and 
in those participating in the latter plus exercise training (white bars, intensive). Model 1: 
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unadjusted; Model 2: analyses were adjusted with baseline values and changes in 
height; Model 3: analyses were adjusted with baseline values and changes in fat mass 
index; Model 4: analyses were adjusted with baseline values and changes in abdominal 
fat. **: P<0.01. 
 
Supplemental Figure 2. Adjusted  effect size (d-Cohen and 95 %CI) and differences in 
the change in percentage hepatic fat, body mass and composition, cardiometabolic and 
diabetes risk factors between the control group (children participating in the family 
based lifestyle and psycho-educational program) and the intensive group (children 
participating in the multicomponent intervention including lifestyle and psycho-
educational program and exercise training). Differences between the control and the 
intensive intervention groups in terms of the changes in primary and secondary 
outcomes were examined per protocol by ANCOVA, adjusting for baseline values. 
*Negative Cohen's d values obtained for the differences in the changes in adiposity and 
cardiometabolic and diabetes risk between the two groups (in favor of the intensive 
group) were multiplied by -1 for illustrative purposes. HDL: high density lipoprotein; 
HOMA: homeostasis model assessment; TG/HDL: triglycerides to high density 
lipoprotein ratio; LDL: low density lipoprotein; GGT: gamma glutammyl transferase; 
VO2 peak: peak oxygen consumption in the treadmill test; 20msrt: performance in the 
20 meters shuttle run test. 
 
Supplemental Figure 3. Effect size (d-Cohen and 95 %CI) and differences in the 
change in percentage hepatic fat, body mass and composition, cardiometabolic and 
diabetes risk factors between the control group (children participating in the family 
based lifestyle and psycho-educational program) and the intensive group (children 
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participating in the multicomponent intervention including lifestyle and psycho-
educational program and exercise training). Differences between the control and the 
intensive intervention groups in terms of the changes in primary and secondary 
outcomes were examined on an intention to treat basis ANOVA (unadjusted P) and 
ANCOVA adjusting for baseline values (adjusted P). Changes were calculated as post-
intervention minus pre-intervention values. Data are means (standard deviation). 
*Negative Cohen's d values obtained for the differences in the changes in adiposity and 
cardiometabolic and diabetes risk between the two groups (in favor of the intensive 
group) were multiplied by -1 for illustrative purposes. HDL: high density lipoprotein; 
HOMA: homeostasis model assessment; TG/HDL: triglycerides to high density 
lipoprotein ratio; LDL: low density lipoprotein; GGT: gamma glutamyl transferase; 
VO2 peak: peak oxygen consumption in the treadmill test; 20msrt: performance in the 




Table 1. Characteristics of the children participating in the study. 
  Total   Control group (CI) Intensive group (II) P 
 N Mean SD N Mean SD N Mean SD  
Age (years) 116 10.6 1.1 57 10.6  1.1 59 10.5 1.0 0.701 
Girls (n, %) 116 62 53.4 57 30 52.6 59 32 54.2 0.862 
Non-Spanish origin of the mother (N, %) 116 18 15.5 57 6 10.5 59 12 20.3 0.114 
High maternal educational level (N, %) 115 84 73.0 57 46 80.7 58 38 65.5 0.092 
Family history of diabetes (N, %) 115 9 7.8 57 7 11.3 58 2 4.0 0.094 
Tanner stage (N, %)           
Telarche or gonadarche 108   55   53   0.277 
I  38 34.3  20 36.4  22 41.7  
II  30 38.9  20 36.4  12 22.6  
III  19,  15.7  12 21.0  11 20.8  
IV-V  10 11.1  3 5.4  8 15.1  
Pubarche 108   55   53   0.865 
I  37 34.3  20, 36.4   17 32.1  
II  42 38.9  22, 40.0   20 37.7  
III  17 15.7  7, 12.7   10 18.9  
IV-V  12 11.1  6, 10.9   6 11.3  
Weight status 116   57   59   0.727 
Overweight (N, %)  49 42.3  25 43.9  24 40.7  
Obesity grade I (N, %)  58 50.0  29 50.9  29 49.2  
Obesity grade II (N, %)  6 5.2  2 3.5  4 6.8  
Obesity grade III (N, %)  3 2.6  1 1.8  2 3.4  
High blood pressure  
(N, %) 
116 8 6.9 57 3  5.3 59 5 8.5 0.350 
Hypertriglyceridaemia (N, %) 115 9 7.8 57 3 5.3 58 6 10.3 0.490 
High TG/HDLc (N, %) 114 37 32. 56 17 30.4 58 20 34.5 0.692 
Hepatic steatosis (N, %) 115 41 35.7 57 18 31.6 58 23 39.7 0.239 
Insulin resistance (N, %) 114 51 44.7 55 24 42.9 58 27 46.6 0.705 
Control group: children participating in the family-based lifestyle and psycho-educational program; Intensive group: children participating in the same 




Table 2. Percentage hepatic fat, body composition, cardiometabolic and diabetes risk factors, and physical fitness before (Pre) and after (Post) participation in 
the family-based lifestyle and psycho-educational intervention program (control group, CI) or the plus exercise training (intensive group, II) in children with 
overweight/obesity (per protocol analysis). 
   Control group (CI)    Intensive group (II)  CI vs. II 
  Pre  Post  P   Pre  Post  P  PPre 
 N Mean SD Mean SD   N Mean SD Mean SD    
Abdominal adipose tissue                
Visceral adipose tissue 50 5.2 2.8 5.2  2.9 0.769  49 5.6 4.5 4.5 3.6 0.006  0.836 
Visceral adipose tissue L2-L3 (cm2)                
Fat fraction VAT L2-L3 (%)                
Visceral adipose tissue L3 (cm2)                
Fat fraction VAT L3 (%)                
Visceral adipose tissue L4-L5 (cm2)                
Fat fraction VAT L4-L5 (%)                
Subcutaneous adipose tissue           
Subcutaneous adipose tissue L2-L3 (cm2)                
Fat fraction ASAT L2-L3 (%)                
Subcutaneous adipose tissue L3 (cm2)                
Fat fraction ASAT L3 (%)                
Subcutaneous adipose tissue L4-L5 (cm2)                
Fat fraction ASAT L4-L5 (%)                
Subcutaneous adipose tissue L2-L3 (cm2)                
Fat free abdominal tissue                 
Muscular tissue                 
Muscular tissue L2-L3 (cm2)                
Fat fraction AMT L2-L3 (%)                
Muscular tissue L3 (cm2)                
Fat fraction AMT L3 (%)               0.010 
Muscular tissue L4-L5 (cm2)               0.365 
Fat fraction AMT L4-L5 (%)               0.284 
Psoas (cm2)               0.229 
               0.130 
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SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure calculated as diastolic pressure + [0.333 × (systolic blood pressure - 
diastolic pressure)]; HDLc: high density lipoprotein cholesterol; LDLc: low density lipoprotein cholesterol; TG/HDLc: triglycerides to high density 
lipoprotein cholesterol ratio; HOMA: homeostasis model assessment; Gamma-GT: gamma-glutamyl transferase. 20msrt: 20 meters shuttle run test. 
*Analyzed with log (ln) transformed values, but non-transformed data are shown in table. P indicates statistical differences between Pre and Post values 
(paired Student t test). Ppre indicates statistical differences in baseline values (Student t test). Ppost indicates statistical differences in Post-intervention values 
between the control and the intensive intervention groups (Student t test). 
 
 
